1-3 of 3
Malgorzata Calbecka, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Elzbieta Iskierka-Jazdzewska, MD, Anna Stepien, MSc, Federico Canzian, PhD, Alessandro Martino, PhD, Daniele Campa, PhD, Angelika Stein, Malgorzata Krawczyk-Kulis, MD PhD, Malwina Rybicka, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Aleksandra K. Butrym, MD PhD, Grzegorz Mazur, MD PhD, Artur J. Jurczyszyn, MD PhD, Daria Zawirska, MD PhD, Norbert Grzasko, MD PhD, Waldemar Tomczak, MD PhD, Edyta Subocz, MD PhD, Marzena Watek, MD, Marcin Pasiarski, MD PhD, Marcin Rymko, MD PhD, Malgorzata Calbecka, MD PhD, Agnieszka Druzd-Sitek, PhD, Jan Walewski, MD PhD, Marcin Kruszewski, MD PhD, Malgorzata Razny, MD PhD, Jan M Zaucha, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3628.
https://doi.org/10.1182/blood.V124.21.3628.3628
Published: 2014
Journal Articles

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

Anna Stepien, MSc, Alessandro Martino, PhD, Federico Canzian, PhD, Daniele Campa, PhD, Angelika Stein, Joanna Gora-Tybor, MD PhD, Tomasz Sacha, MD PhD, Dorota Link-Lenczowska, PhD, Izabela Florek, PhD, Witold Prejzner, MD PhD, Zofia Specht-Szwoch, Malgorzata Calbecka, MD PhD, Marcin Rymko, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Tadeusz Robak, MD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5222.
https://doi.org/10.1182/blood.V124.21.5222.5222
Published: 2014
Journal Articles

Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib

Joanna Gora-Tybor, MD, PhD, Ewa Medras, MD, PhD, Malgorzata Calbecka, MD, PhD, Agnieszka Kolkowska, MD, Edyta Ponikowska-Szyba, MD, Tadeusz Robak, MD, PhD, Krzysztof Jamroziak, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1491.
https://doi.org/10.1182/blood.V122.21.1491.1491
Published: 2013